**Core Concept**
Long-acting insulin analogs are designed to provide a steady, basal level of insulin throughout the day, mimicking the body's natural insulin production. These agents have a longer duration of action compared to short- or rapid-acting insulin, allowing for once-daily dosing and improved glycemic control.

**Why the Correct Answer is Right**
Insulin glargine is a long-acting insulin analog that is absorbed slowly and has a prolonged duration of action, typically lasting between 24-42 hours. It is formulated with an acidic solution that delays its absorption, resulting in a flat, basal insulin profile. This makes it an ideal choice for patients who require continuous insulin coverage throughout the day.

**Why Each Wrong Option is Incorrect**
**Option B:** Insulin Lispro is a rapid-acting insulin analog that is absorbed quickly, with an onset of action within 15 minutes and a peak effect at 1-2 hours. It is not suitable for long-term, basal insulin coverage.
**Option C:** Insulin aspart is also a rapid-acting insulin analog, with a similar onset and peak effect profile as insulin Lispro. It is not designed for long-term, basal insulin coverage.
**Option D:** Insulin glulisine is another rapid-acting insulin analog, with a similar profile to insulin Lispro and insulin aspart. It is not suitable for long-term, basal insulin coverage.

**Clinical Pearl / High-Yield Fact**
When selecting a long-acting insulin, it's essential to consider the patient's lifestyle and insulin dosing schedule. Insulin glargine is often preferred for patients who require a once-daily dosing regimen, while insulin detemir may be a better option for patients who require more flexibility in their dosing schedule.

**✓ Correct Answer: A. Insulin glargine**